SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024062
Filing Date
2021-05-05
Accepted
2021-05-05 16:13:00
Documents
48
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alec-10q_20210331.htm   iXBRL 10-Q 1814027
2 EX-31.1 alec-ex311_47.htm EX-31.1 18405
3 EX-31.2 alec-ex312_48.htm EX-31.2 18411
4 EX-32.1 alec-ex321_8.htm EX-32.1 9481
5 EX-32.2 alec-ex322_7.htm EX-32.2 9517
  Complete submission text file 0001564590-21-024062.txt   4927706

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alec-20210331.xsd EX-101.SCH 29213
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alec-20210331_cal.xml EX-101.CAL 32572
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alec-20210331_def.xml EX-101.DEF 93155
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20210331_lab.xml EX-101.LAB 262259
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20210331_pre.xml EX-101.PRE 189246
11 EXTRACTED XBRL INSTANCE DOCUMENT alec-10q_20210331_htm.xml XML 649569
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 21893383
SIC: 2836 Biological Products, (No Diagnostic Substances)